The Immuno-Oncology Lab stands out for its ability to generate transformative technological innovations, culminating in the registration of patents that represent original and applicable solutions in the field of cancer immunotherapy. These patents testify to the scientific rigor and pioneering approach of the laboratory, translating our research results into concrete applications for the development of peptide molecules, predictive biomarkers and new therapeutic platforms. Each patent is the result of multidisciplinary work aimed at overcoming existing barriers in cancer treatment.